NCT01261754View on ClinicalTrials.gov

A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 29, 2012

Conditions
Prostate Cancer
Interventions
RADIATION

99mTc MIP 1404

Subjects will be administered a single 20 (± 3) mCi intravenous (IV) injection of 99mTc MIP 1404

RADIATION

99mTc MIP 1405

Subjects will be administered a single 20 (± 3) mCi intravenous (IV) injection of 99mTc MIP 1405

Trial Locations (1)

10065

New York Presbyterian Hospital - Weill Medical College of Cornell University, New York

Sponsors
All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY